INFLUENCE OF DOPAMINERGIC, ADRENERGIC AND CHOLINERGIC BLOCKADE AND TRH ADMINISTRATION ON GH RESPONSES TO GRF 1–29
- 17 March 1986
- journal article
- research article
- Published by Wiley in Clinical Endocrinology
- Vol. 24 (3), 291-298
- https://doi.org/10.1111/j.1365-2265.1986.tb03270.x
Abstract
In order to establish the influence of dopaminergic, á‐adrenergic and cholinergic pathways on GRF‐mediated GH release we have studied the GH responses to GRF 1–29 (100 or 50 μg as i.v. bolus) alone and in combination with metoclopramide (MCP, 10 mg, i.v.), thymoxamine (THYM, 210 μg/min, 150 min infusion), and atropine (1.2 mg, i.v.). We have also investigated any possible interaction between TRH and GRF in view of the reported inhibitory effects of TRH infusion on stimulated GH release. Dopaminergic and á‐adrenergic blockade with MCP and THYM respectively, did not have any effect on the GH responses to GRF. This lack of effect strongly suggests that any action which these neurotransmitters may exert on GH secretion is not at a pituitary level. TRH did not modify the GH response to GRF suggesting that the inhibitory effect on stimulted GH secretion is exerted at a hypothalamic level. In contrast, GH responses to GRF were significantly reduced by prior administration of atropine. These data support the view that cholinergic pathways play an important role in the regulation of GH secretion and such control may be exerted at both hypothalamic and pituitary levels.This publication has 36 references indexed in Scilit:
- THE EFFECTS OF CHOLINERGIC BLOCKADE ON THE GROWTH HORMONE AND PROLACTIN RESPONSE TO INSULIN HYPOGLYCAEMIAClinical Endocrinology, 1985
- INHIBITION OF PHYSIOLOGICAL GROWTH HORMONE SECRETION BY ATROPINEClinical Endocrinology, 1985
- EFFECTS OF GRF(1–40) AND DOMPERIDONE ON GH SECRETION IN NORMAL MANClinical Endocrinology, 1984
- RESPONSES TO ANALOGUES OF GROWTH HORMONE-RELEASING HORMONE IN NORMAL SUBJECTS, AND IN GROWTH-HORMONE DEFICIENT CHILDREN AND YOUNG ADULTSClinical Endocrinology, 1984
- EFFECTS OF HUMAN PANCREATIC TUMOUR GROWTH HORMONE RELEASING FACTOR ON GROWTH HORMONE AND SOMATOMEDIN C LEVELS IN PATIENTS WITH IDIOPATHIC GROWTH HORMONE DEFICIENCYThe Lancet, 1983
- HUMAN PANCREATIC GROWTH-HORMONE-RELEASING FACTOR SELECTIVELY STIMULATES GROWTH-HORMONE SECRETION IN MANThe Lancet, 1983
- Plasma Pharmacokinetics of Intravenously Administered Atropine in Normal Human SubjectsThe Journal of Clinical Pharmacology, 1982
- OPIATES CONTROL ACTH THROUGH A NORADRENERGIC MECHANISMClinical Endocrinology, 1982
- EFFECTS OF PROSOMATOSTATIN ON GROWTH HORMONE AND PROLACTIN RESPONSE TO ARGININE IN MAN Comparison with SomatostatinThe Lancet, 1981
- Adrenergic receptor control mechanism for growth hormone secretionJCI Insight, 1968